摘要
目的:探讨氨磺必利治疗慢性精神分裂症的临床疗效。方法:对30例诊断慢性精神分裂症患者,给予氨磺必利治疗,分别在治疗前,治疗后2周末,治疗后4周末,治疗量8周末采用阳性与阴性症状量表(PANSS)评定临床疗效。结果:治疗前后PANSS量表总分比较有显著性差异(P<0.01～0.05)。结论:氨磺必利对慢性精神分裂症的治疗疗效较好,不良反应较轻,值得临床推广。
Objective： Discussion of amisulpride in the treatment of chronic schizophrenia clinical curative effect. Methods： In 30 patients with chronic schizophrenia diagnostic criteria for patients, give amisulpride treatment, respectively, before treatment, 2 weeks after the treatment, 4 weeks after the treatment, the treatment volume 8 weekend with the positive and negative symptom scale （PANSS） assessment of clinical efficacy. Results： Before and after treatment with PANSS Scale total scores showed significant differences （P 〈0.01 -0.05 ）. Conclusions： amisulpride in the treatment of chronic schizophrenia curative effect is better, with mild adverse reactions, worthy of clinical application.
出处
《中国民康医学》
2013年第9期18-19,共2页
Medical Journal of Chinese People’s Health
